Skip to main content
. 2020 Oct 28;2020(10):CD013400. doi: 10.1002/14651858.CD013400.pub2

UMIN000021661.

Study name Evaluation test about safety and efficacy of the respiratory muscle training therapy by abdominal respiratory weight exercises in chronic cardiovascular disease patients
Methods Parallel randomized
Participants Inclusion criteria:
  • Patients with chronic cardiovascular disease in outpatient or in hospital of Kurume University hospital

  • Patients with informed consent

  • Patients with chronic cardiovascular disease shown in the following

  • Ischaemic heart disease

  • Valvular heart disease

  • Hypertensive heart disease

  • Cardiomyopathy

  • Arrhythmia

  • Adult congenital heart disease

  • Pulmonary hypertension

  • Exclusion criteria: Patients with obstructive respiratory disease

  • Patients with the device planted

  • Patients with difficult musculoskeletal disease

  • Patients with symptoms at rest

  • Patients with pulmonary hypertension of the WHO classification 3 more

  • Patients with hypoxaemia in spite of the use of breathing ancillary equipment

  • Patients with uncontrolled high blood pressure

  • Patients with poor control of arrhythmia, such as adverse effects on haemodynamics

  • Patients that may be in or pregnancy

  • Others, patients who are judged that this study is unsuitable by physician

Interventions The respiratory muscle training therapy is performed in addition to performing conventional cardiac rehabilitation. The respiratory muscle training therapy is abdominal muscle training method. Intervention period is 6 months
Outcomes
  • Cardiac function

  • Respiratory function

  • Exercise capacity

  • Relief of symptoms

  • Autonomic function

  • Body composition

  • Physical function

  • Carbohydrate metabolism

  • Lipid metabolism

Starting date 4 April 2016
Contact information Miki Biwa
biwa_miki@med.kurume‐u.ac.jp
Notes